Microrna Target Site Blocking Oligos And Uses Thereof - EP2113567

The patent EP2113567 was granted to Exiqon on Apr 3, 2019. The application was originally filed on Dec 21, 2007 under application number EP09165187A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2113567

EXIQON
Application Number
EP09165187A
Filing Date
Dec 21, 2007
Status
Opposition Rejected
Mar 18, 2022
Grant Date
Apr 3, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

RANGER BIOTECHNOLOGIESJan 3, 2020BUDDE SCHOUADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONWO2008061537
OTHERWO2008061537
SEARCHCN101054576
SEARCHCN101054580
SEARCHUS2007065840
SEARCHWO2005111211
SEARCHWO2006069584

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- Jiening Xiao ET AL, "Retracted: Novel approaches for gene-specific interference via manipulating actions of microRNAs: Examination on the pacemaker channel genes HCN2 and HCN4", Journal of Cellular Physiology, (20070821), vol. 212, no. 2, doi:10.1002/jcp.21062, ISSN 0021-9541, pages 285 - 292, XP055199875
OPPOSITION- XIAO JIENING ET et al., "Novel approaches for gene -specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4", JOURNAL OF CELLULAR PHYSIOLOGY AUG 2007, (20070800), vol. 212, no. 2, doi:10.1002/jcp.21062, pages 285 - 292, XP002481763
OTHER- KLEIN M.E. ET AL, "Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA", NATURE NEUROSCIENCE, (200712), vol. 10, no. 12, XP003028045
SEARCH- XIAO JIENING ET AL, "Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4.", JOURNAL OF CELLULAR PHYSIOLOGY AUG 2007, (200708), vol. 212, no. 2, ISSN 0021-9541, pages 285 - 292, XP002481763 [PX] 1-15 * the whole document *
SEARCH- VATOLIN ET AL, "A Novel Method to Detect Functional MicroRNA Targets", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, (20060512), vol. 358, no. 4, ISSN 0022-2836, pages 983 - 996, XP005392551 [A] * the whole document *
SEARCH- LEWIS B P, "Prediction of Mammalian MicroRNA Targets", CELL, CELL PRESS, CAMBRIDGE, NA, US, (20031226), vol. 115, no. 7, ISSN 0092-8674, pages 787 - 798, XP002295226 [A] * the whole document *
SEARCH- LIM L P ET AL, "Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs", NATURE, NATURE PUBLISHING GROUP, LONDON, (20050217), vol. 433, no. 7027, ISSN 0028-0836, pages 769 - 773, XP002994329
SEARCH- WANG XIU-JIE ET AL, "Prediction and identification of Arabidopsis thaliana microRNAs and their mRNA targets", GENOME BIOLOGY, BIOMED CENTRAL LTD., LONDON, GB, (20040831), vol. 5, no. 9, ISSN 1465-6906, page R65, XP021012924 [A] * the whole document *
SEARCH- JOHN BINO ET AL, "Human MicroRNA targets.", PLOS BIOLOGY NOV 2004, (200411), vol. 2, no. 11, ISSN 1545-7885, page e363, XP002481762 [A] * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents